302 related articles for article (PubMed ID: 16557436)
1. Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma.
Urano N; Fujiwara Y; Doki Y; Tsujie M; Yamamoto H; Miyata H; Takiguchi S; Yasuda T; Yano M; Monden M
Gastric Cancer; 2006; 9(1):44-9. PubMed ID: 16557436
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma.
Ma J; Zhang L; Ru GQ; Zhao ZS; Xu WJ
World J Gastroenterol; 2007 Mar; 13(11):1680-6. PubMed ID: 17461470
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic significance of hypoxia-inducible factor 1alpha overexpression in gastric carcinomas.
Mizokami K; Kakeji Y; Oda S; Irie K; Yonemura T; Konishi F; Maehara Y
J Surg Oncol; 2006 Aug; 94(2):149-54. PubMed ID: 16847924
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic significance of HIF-1alpha, p53, and VEGF expression and preoperative serum VEGF level in gastric cancer.
Oh SY; Kwon HC; Kim SH; Jang JS; Kim MC; Kim KH; Han JY; Kim CO; Kim SJ; Jeong JS; Kim HJ
BMC Cancer; 2008 May; 8():123. PubMed ID: 18452596
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival.
Cabuk D; Basaran G; Celikel C; Dane F; Yumuk PF; Iyikesici MS; Ekenel M; Turhal NS
Oncology; 2007; 72(1-2):111-7. PubMed ID: 18025805
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer.
Sumiyoshi Y; Kakeji Y; Egashira A; Mizokami K; Orita H; Maehara Y
Clin Cancer Res; 2006 Sep; 12(17):5112-7. PubMed ID: 16951228
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of the expression of vascular endothelial growth factor A and hypoxia-inducible factor 1alpha in patients undergoing surgery for non-small cell lung cancer].
Honguero Martínez AF; Arnau Obrer A; Figueroa Almazán S; Martínez Hernández N; Guijarro Jorge R
Med Clin (Barc); 2014 May; 142(10):432-7. PubMed ID: 23948151
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of hypoxia-inducible factor 1α, and its correlation with p53 and vascular endothelial growth factor expression in resectable esophageal squamous cell carcinoma.
Shao N; Han Y; Song L; Song W
J Cancer Res Ther; 2020; 16(2):269-275. PubMed ID: 32474512
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
Schindl M; Schoppmann SF; Samonigg H; Hausmaninger H; Kwasny W; Gnant M; Jakesz R; Kubista E; Birner P; Oberhuber G;
Clin Cancer Res; 2002 Jun; 8(6):1831-7. PubMed ID: 12060624
[TBL] [Abstract][Full Text] [Related]
10. Is the hypoxia-inducible factor pathway important in gastric cancer?
Griffiths EA; Pritchard SA; Welch IM; Price PM; West CM
Eur J Cancer; 2005 Dec; 41(18):2792-805. PubMed ID: 16290133
[TBL] [Abstract][Full Text] [Related]
11. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer.
Isobe T; Aoyagi K; Koufuji K; Shirouzu K; Kawahara A; Taira T; Kage M
Int J Clin Oncol; 2013 Apr; 18(2):293-304. PubMed ID: 22350022
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
[TBL] [Abstract][Full Text] [Related]
14. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
[TBL] [Abstract][Full Text] [Related]
15. Significance of Akt phosphorylation on tumor growth and vascular endothelial growth factor expression in human gastric carcinoma.
Kobayashi I; Semba S; Matsuda Y; Kuroda Y; Yokozaki H
Pathobiology; 2006; 73(1):8-17. PubMed ID: 16785763
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases.
Shimomura M; Hinoi T; Kuroda S; Adachi T; Kawaguchi Y; Sasada T; Takakura Y; Egi H; Okajima M; Tashiro H; Nishizaka T; Ohdan H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S527-36. PubMed ID: 23748663
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaB.
Rohwer N; Dame C; Haugstetter A; Wiedenmann B; Detjen K; Schmitt CA; Cramer T
PLoS One; 2010 Aug; 5(8):e12038. PubMed ID: 20706634
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia.
Fu Z; Chen D; Cheng H; Wang F
Med Sci Monit; 2015 Jan; 21():318-25. PubMed ID: 25623525
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia inducible factor-alpha expression correlates with vascular endothelial growth factor-C expression and lymphangiogenesis/angiogenesis in oral squamous cell carcinoma.
Liang X; Yang D; Hu J; Hao X; Gao J; Mao Z
Anticancer Res; 2008; 28(3A):1659-66. PubMed ID: 18630523
[TBL] [Abstract][Full Text] [Related]
20. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
